David García‐Azorín

5.1k total citations · 3 hit papers
148 papers, 2.2k citations indexed

About

David García‐Azorín is a scholar working on Psychiatry and Mental health, Neurology and Pathology and Forensic Medicine. According to data from OpenAlex, David García‐Azorín has authored 148 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Psychiatry and Mental health, 53 papers in Neurology and 51 papers in Pathology and Forensic Medicine. Recurrent topics in David García‐Azorín's work include Migraine and Headache Studies (88 papers), Trigeminal Neuralgia and Treatments (42 papers) and Long-Term Effects of COVID-19 (37 papers). David García‐Azorín is often cited by papers focused on Migraine and Headache Studies (88 papers), Trigeminal Neuralgia and Treatments (42 papers) and Long-Term Effects of COVID-19 (37 papers). David García‐Azorín collaborates with scholars based in Spain, Italy and United Kingdom. David García‐Azorín's co-authors include Ángel L. Guerrero, Álvaro Planchuelo‐Gómez, César Fernández‐de‐las‐Peñas, Rodrigo de Luis‐García, J. Porta‐Etessam, María L. Cuadrado, Andrea Sylvia Winkler, Álvaro Sierra, Santiago Aja‐Fernández and Ana Beatriz Gago‐Veiga and has published in prestigious journals such as SHILAP Revista de lepidopterología, NeuroImage and Neurology.

In The Last Decade

David García‐Azorín

139 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Changes in cognitive functioning after COVID‐19: A systematic review and meta‐analysis

2022 203 citations David García‐Azorín et al. profile →
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials

2023 76 citations Faraidoon Haghdoost, Francesca Puledda et al. Cephalalgia profile →
Health equity, care access and quality in headache – part 1

2024 34 citations Claudio Tana, Bianca Raffaelli et al. The Journal of Headache and Pain profile →

Peers

David García‐Azorín

NEURO

PMH

PFM

Lidiane Lima Florêncio Spain

Ángel L. Guerrero Spain

Rebecca De Lorenzo Italy

R. Ross Reichard United States

Ayush Batra United States

Sierra Luciano United Kingdom

Clotilde Boulay France

Piergiorgio Lochner Italy

Marcos José Navarro‐Santana Spain

Wanzhu Bai China

Lidiane Lima Florêncio Spain

David García‐Azorín

1.0k ×0.9

NEURO

1.4k ×1.4

PMH

514 ×1.0

303 ×0.7

722 ×1.9

PFM

Citations per year, relative to David García‐Azorín David García‐Azorín (= 1×) peers Lidiane Lima Florêncio

Countries citing papers authored by David García‐Azorín

Since Specialization

Citations

This map shows the geographic impact of David García‐Azorín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David García‐Azorín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David García‐Azorín more than expected).

Fields of papers citing papers by David García‐Azorín

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David García‐Azorín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David García‐Azorín. The network helps show where David García‐Azorín may publish in the future.

Co-authorship network of co-authors of David García‐Azorín

This figure shows the co-authorship network connecting the top 25 collaborators of David García‐Azorín. A scholar is included among the top collaborators of David García‐Azorín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David García‐Azorín. David García‐Azorín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

López-Bravo, A., Ane Mínguez‐Olaondo, Alicia Alpuente, et al.. (2025). Patient satisfaction with calcitonin gene‐related peptide monoclonal antibodies in migraine: A multicenter prospective cohort study. Headache The Journal of Head and Face Pain. 65(6). 994–1004. 2 indexed citations

Río, Margarita Sánchez del, et al.. (2025). Prevalence, disability, and economic impact of migraine in Spain: a nationwide population-based study. The Journal of Headache and Pain. 26(1). 117–117. 1 indexed citations

Tana, Claudio, Dilara Onan, Roberta Messina, et al.. (2025). From Headache to Heart Health: Investigating the Migraine–Cardiovascular Disease Connection. Neurology and Therapy. 14(4). 1229–1268. 1 indexed citations

Chaudhry, Basit Ali, Samaira Younis, Roberta Messina, et al.. (2025). Cortical thickness studies in migraine: Current evidence and future directions. Cephalalgia. 45(6). 2235386260–2235386260.

Tana, Claudio, Bianca Raffaelli, Marcio Nattan Portes Souza, et al.. (2024). Health equity, care access and quality in headache – part 1. The Journal of Headache and Pain. 25(1). 12–12. 34 indexed citations breakdown →

Pulido, Paloma, Javier López, Isidre Vilacosta, et al.. (2024). Embolic Events in Infective Endocarditis: A Comprehensive Review. Reviews in Cardiovascular Medicine. 25(3). 97–97. 4 indexed citations

García‐Azorín, David, Ana Beatriz Gago‐Veiga, Vicente González‐Quintanilla, et al.. (2024). CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine. Cephalalgia. 44(4). 2225293889–2225293889. 3 indexed citations

Puledda, Francesca, Irene de Boer, Roberta Messina, et al.. (2024). Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society. Cephalalgia. 44(11). 2225342744–2225342744. 7 indexed citations

García‐Azorín, David, et al.. (2023). Increased MRI-based Brain Age in chronic migraine patients. The Journal of Headache and Pain. 24(1). 133–133. 6 indexed citations

10.

Haghdoost, Faraidoon, et al.. (2023). Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials. Cephalalgia. 43(4). 2215204422–2215204422. 76 indexed citations breakdown →

11.

Caronna, Edoardo, Thomas C. van den Hoek, Hayrünnisa Bolay, et al.. (2023). Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive review. Cephalalgia. 43(1). 2205176393–2205176393. 17 indexed citations

12.

García‐Azorín, David, et al.. (2023). Differential Diagnosis of Visual Phenomena Associated with Migraine: Spotlight on Aura and Visual Snow Syndrome. Diagnostics. 13(2). 252–252. 8 indexed citations

13.

García‐Azorín, David, Almudena Layos-Romero, J. Porta‐Etessam, et al.. (2022). Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients. Cephalalgia. 42(8). 804–809. 56 indexed citations

14.

García‐Azorín, David, N. González-García, Esther Rodríguez‐Adrada, et al.. (2022). Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection. Cephalalgia. 42(14). 1521–1531. 9 indexed citations

15.

García‐Azorín, David, N. González-García, Alberto Marcos Dolado, et al.. (2021). Management of thunderclap headache in the emergency room: A retrospective cohort study. Cephalalgia. 41(6). 711–720. 5 indexed citations

16.

Pohl, Heiko, et al.. (2021). Time lost due to an attack – a novel patient-reported outcome measure for acute migraine treatments. Cephalalgia. 41(9). 1027–1032. 2 indexed citations

17.

Cuffaro, Luca, Vanessa Carvalho, Giovanni Di Liberto, et al.. (2020). Neurology training and research in the COVID‐19 pandemic: a survey of the Resident and Research Fellow Section of the European Academy of Neurology. European Journal of Neurology. 28(10). 3437–3442. 10 indexed citations

18.

Porta‐Etessam, J., Jordi A. Matías‐Guiu, N. González-García, et al.. (2020). Spectrum of Headaches Associated With SARS‐CoV‐2 Infection: Study of Healthcare Professionals. Headache The Journal of Head and Face Pain. 60(8). 1697–1704. 49 indexed citations

19.

García‐Azorín, David, Javier Trigo, Blanca Talavera, et al.. (2020). Frequency and Type of Red Flags in Patients With Covid‐19 and Headache: A Series of 104 Hospitalized Patients. Headache The Journal of Head and Face Pain. 60(8). 1664–1672. 32 indexed citations

20.

Sierra, Álvaro, David García‐Azorín, Javier Trigo, et al.. (2020). Clinical characterization of headache attributed to COVID-19: A series of 457 cases. Cephalalgia. 40. 10–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact